Abdollahi Reihaneh, Abiri Behnaz, Sarbakhsh Parvin, Kashanian Maryam, Vafa Mohammadreza
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Department of Nutrition, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran,
Complement Med Res. 2019;26(5):336-342. doi: 10.1159/000500016. Epub 2019 May 17.
Premenstrual syndrome (PMS) alludes to a cyclic advent of somatic and psychiatric symptoms that affect some women of reproductive age. Some studies demonstrated that vitamin D was associated with premenstrual symptoms.
The aim of this study was to evaluate the effect of vitamin D supplementation in the treatment of PMS in vitamin D-deficient young girls.
In this randomized double-blind placebo-controlled trial, 130 vitamin D-deficient girls aged 18-30 years, with PMS, were randomly divided into 2 groups and received a 2,000 IU vitamin D tablet (n = 64) or a placebo (n = 66) every other day for 12 weeks. At the beginning and at the end of week 12, serum 25(OH)-D, premenstrual symptoms, anthropometric indices, dietary intake, physical activity level, and sun exposure were evaluated. Statistical analysis was performed using SPSS version 20. p < 0.05 was considered statistically significant.
Serum 25(OH)-D levels were significantly elevated in the vitamin D group in comparison to the placebo group after 12 weeks (p < 0.001). There was no significant difference between the 2 groups with regard to 14 symptoms of PMS after 12 weeks of intervention, even after adjustment for the baseline values of anxiety, weeping, and hypersomnia (for all symptoms, p > 0.05). However, in the vitamin D group, scores of nervousness (p < 0.001), job activity reduction (p = 0.01), social activity reduction (p = 0.01), fatigue (p < 0.001), and physical symptoms (p = 0.00) were reduced at the end of the intervention, and these changes were statistically significant compared to baseline. However, these alterations did not reach significance compared with the placebo group (p > 0.05).
It seems that 2,000 IU vitamin D consumption in the vitamin D-deficient young girls with PMS every other day for 12 weeks had no significant impact on other PMS symptoms.
经前期综合征(PMS)是指一些育龄女性会周期性出现的躯体和精神症状。一些研究表明,维生素D与经前期症状有关。
本研究旨在评估补充维生素D对维生素D缺乏的年轻女孩经前期综合征的治疗效果。
在这项随机双盲安慰剂对照试验中,130名年龄在18 - 30岁、患有经前期综合征且维生素D缺乏的女孩被随机分为两组,每隔一天分别服用2000国际单位的维生素D片(n = 64)或安慰剂(n = 66),持续12周。在第12周开始和结束时,评估血清25(OH)-D、经前期症状、人体测量指标、饮食摄入量、身体活动水平和日照情况。使用SPSS 20版进行统计分析。p < 0.05被认为具有统计学意义。
12周后,维生素D组的血清25(OH)-D水平与安慰剂组相比显著升高(p < 0.001)。干预12周后,两组在经前期综合征的14项症状方面没有显著差异,即使在对焦虑、哭泣和失眠的基线值进行调整后也是如此(所有症状,p > 0.05)。然而,在维生素D组中,干预结束时紧张程度(p < 0.001)、工作活动减少(p = 0.01)、社交活动减少(p = 0.01)、疲劳(p < 0.001)和身体症状(p = 0.00)的评分降低,与基线相比这些变化具有统计学意义。然而,与安慰剂组相比,这些改变没有达到显著水平(p > 0.05)。
对于患有经前期综合征的维生素D缺乏年轻女孩,每隔一天服用2000国际单位维生素D持续12周,似乎对其他经前期综合征症状没有显著影响。